Crombie JL, Redd R, Phinney C, Forsyth M, et al. A multicenter phase II study of glofitamab plus polatuzumab-R-CHP for patients with diffuse large B-cell lymphoma. Blood 2026 Oct 6:blood.2026034588. doi: 10.1182/blood.2026034588.
PMID: 42837325